FAQs on Myeloma Updates from ASCO & EHA 2025 скачать в хорошем качестве

FAQs on Myeloma Updates from ASCO & EHA 2025

Chris Peña, Director of Education Programs at the Multiple Myeloma Research Foundation, gets updates on the latest multiple myeloma treatment research from Dr. Faith Davies (Director Myeloma Clinical Program, NYU Langone Health; Professor of Medicine, NYU Grossman School of Medicine, New York, New York) and Dr. Omar Nadeem (Clinical Director, Myeloma Immune Effector Cell Therapy Program; Associate Director, Myeloma Clinical Research Program, Dana-Farber Cancer Institute; Instructor of Medicine, Harvard Medical School, Boston, Massachusetts). Dr. Davies and Dr. Nadeem provide updates about the latest myeloma clinical research as presented at the American Society of Clinical Oncology (ASCO) Annual Meeting held May 30, 2025, in Chicago, Illinois, and the European Hematology Association (EHA) 2025 Congress held June 12-15, 2025. Topics will include… 6:46 Newly Diagnosed Multiple Myeloma 21:55 Relapsed/Refractory Multiple Myeloma This session is supported by Adaptive, Alexion, Bristol Myers Squibb, CURE, Genentech, GSK, Kite/Arcellx, Pfizer, Regeneron, and Sanofi. If you have questions, call our MMRF Patient Navigation Center at 1-888-841-6673.